In ₹ Crore except Per Share 12 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|
| Total Income | 24,169.4 | 38,695.9 | 22,809.2 | 45,803.0 | 5,657.7 | 46,090.7 | |
| Expenses | |||||||
| Total Expenses | 22,606.2 | 38,227.7 | 22,609.1 | 45,375.7 | 3,463.9 | 45,550.8 | |
| Profit | |||||||
| + Current Tax | 60.0 | 45.2 | 18.6 | 44.4 | 51.2 | 47.3 | |
| Revenue Detail — as filed | |||||||
| + Investment Income | 251.1 | 292.9 | 322.3 | 356.3 | 326.0 | 281.6 | |
| + Income from Investments (net) | -1,040.8 | 21,525.1 | -2,055.3 | 15,531.0 | -23,938.7 | 25,977.0 | |
| Expense Detail — as filed | |||||||
| + Advertisement & Publicity | 76.0 | 43.8 | 42.1 | 56.6 | 95.7 | 54.3 | |
| + Employee Remuneration & Welfare | 681.9 | 709.2 | 827.9 | 1,007.8 | 706.9 | 798.6 | |
| + Commission | 997.8 | 666.0 | 1,240.3 | 1,610.2 | 859.1 | 929.6 | |
| + Commission (net) | 776.8 | 786.1 | 1,240.3 | 1,610.2 | 859.1 | 929.6 | |
| + Provision — Diminution in Investments | 6.5 | -12.4 | 42.1 | -0.8 | -21.1 | -0.3 | |
| + Provision — Doubtful Debts & Write-offs | 0.1 | 0.3 | 0.2 | 0.2 | 0.3 | 0.1 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||||
| Profit / (Loss) before Tax | 840.6 | 610.9 | 513.2 | 597.5 | 815.8 | 745.9 | |
| + Current Taxes | 27.1 | 16.6 | 18.6 | 20.8 | 11.1 | 20.9 | |
| + Provision for Tax | 60.0 | 45.2 | 18.6 | 44.4 | 51.2 | 47.3 | |
| + Provisions for Taxes | 27.1 | 16.6 | 18.6 | 20.8 | 11.1 | 20.9 | |
| PAT before Extraordinary Items | 813.5 | 594.4 | 494.6 | 576.7 | 804.6 | 724.9 | |
| PAT after Extraordinary Items | 813.5 | 594.4 | 494.6 | 576.7 | 804.6 | 724.9 | |
| Profit Carried to Balance Sheet | 15,630.6 | 16,224.9 | 16,719.5 | 17,296.2 | 17,830.1 | 18,555.0 | |
| Per Share — as-filed variants | |||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 8.12 | 5.93 | 4.93 | 5.75 | 8.02 | 7.23 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 8.11 | 5.93 | 4.93 | 5.75 | 8.02 | 7.22 | |
| Appropriations & Transfers | |||||||
| Reserves & Surplus excl. Revaluation Reserve | 15,790.7 | 16,405.0 | 16,921.2 | 17,523.3 | 18,083.1 | 18,822.0 | |
| + Interim Dividend | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — Revenue Account (Policyholders') | |||||||
| + Gross Premium Income | 24,001.5 | 17,813.9 | 25,083.9 | 30,449.5 | 27,938.9 | 21,289.7 | |
| + Net Premium Income | 23,860.7 | 17,178.5 | 24,848.3 | 30,245.3 | 27,683.8 | 20,078.2 | |
| + First-year Premium | 4,858.7 | 3,539.5 | 5,289.5 | 7,919.3 | 5,092.7 | 4,954.9 | |
| + Renewal Premium | 14,680.3 | 10,546.3 | 14,002.8 | 17,471.7 | 16,714.0 | 12,381.8 | |
| + Single Premium | 4,462.5 | 3,728.1 | 5,791.6 | 5,058.4 | 6,132.2 | 3,952.9 | |
| + Commission — First-year Premium | 567.1 | 393.5 | 795.3 | 1,085.8 | 416.2 | 612.4 | |
| + Commission — Renewal Premium | 370.8 | 223.9 | 354.2 | 433.8 | 440.3 | 251.5 | |
| + Commission — Single Premium | 59.9 | 48.7 | 90.8 | 90.6 | 2.6 | 65.7 | |
| + Expenses of Management | 2,015.1 | 1,915.2 | 2,759.2 | 3,519.4 | 2,527.4 | 2,565.0 | |
| + Operating Expenses — Insurance Business | 1,238.3 | 1,129.1 | 1,518.9 | 1,909.2 | 1,668.3 | 1,635.5 | |
| + Expenses — Non-insurance | 10.4 | 7.5 | 14.6 | 4.9 | 2.7 | 6.9 | |
| + Benefits Paid (net) | 12,528.3 | 10,118.4 | 13,482.1 | 14,468.4 | 16,254.6 | 13,126.7 | |
| + Change in Actuarial Liability | 7,706.0 | 25,899.9 | 6,039.2 | 27,347.4 | -15,348.4 | 29,811.6 | |
| + Bonus Allocated to Policyholders | 1,967.2 | 0.0 | 0.0 | 0.0 | 2,060.5 | 0.0 | |
| + Interim Bonus Paid | 18.2 | 6.4 | 8.7 | 6.3 | 8.4 | 6.8 | |
| + Terminal Bonus Paid | 163.7 | 83.5 | 147.9 | 183.2 | 258.9 | 127.6 | |
| + GST on Linked Charges | 290.2 | 261.1 | 267.7 | -3.4 | -0.1 | 0.4 | |
| Surplus in the Revenue Account | 1,563.2 | 468.2 | 200.2 | 427.3 | 2,193.8 | 539.9 | |
| Net Surplus / (Deficit) | 1,563.2 | 468.2 | 200.2 | 427.3 | 2,193.8 | 539.9 | |
| + Funds for Future Appropriation | -384.4 | 146.6 | -5.6 | 158.1 | -169.8 | 82.1 | |
| + Policyholders' Liabilities to Shareholders' Fund | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 25.1 | |
| Insurance — Shareholders' Account | |||||||
| + Income under Shareholders' Account | 251.3 | 292.9 | 322.3 | 356.3 | 326.0 | 281.7 | |
| + Shareholders' Account Income | 2,199.0 | 614.4 | 528.1 | 625.5 | 2,689.6 | 739.5 | |
| + Shareholders' Account Expenses | 1,358.4 | 3.5 | 14.9 | 28.0 | 1,873.8 | -6.3 | |
| + Shareholders' Provision — Diminution in Investments | 2.1 | -4.1 | 0.2 | 23.1 | -2.8 | -13.3 | |
| + Transfer from Policyholders' Account | 1,947.7 | 321.5 | 205.7 | 269.2 | 2,363.6 | 457.8 | |
| + Transfer of Funds to Policyholders' Account | 1,345.9 | 0.0 | 0.0 | 0.0 | 1,873.9 | 0.0 | |
| + Transferred to Shareholders' Account | 1,947.7 | 321.5 | 205.7 | 269.2 | 2,363.6 | 457.8 | |
| Shareholders' Fund — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.2 | |
| Shareholders' Fund — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Insurance — Fund NPAs | |||||||
| + Linked Non-participating — with Unrealised Gains | -0.0 | 0.0 | -0.0 | 0.0 | -0.0 | 0.0 | |
| + Linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Participating — with Unrealised Gains | 0.0 | 0.0 | -0.0 | 0.0 | -0.0 | 0.0 | |
| + Non-linked Participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — with Unrealised Gains | 0.0 | 0.0 | -0.0 | 0.0 | -0.0 | 0.0 | |
| + Non-linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||||
| Solvency Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 1.96 | |
| Conservation Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.88 | |
| Expenses of Management Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | |
| Persistency — 13th Month | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.84 | |
| Persistency — 25th Month | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.77 | |
| Persistency — 37th Month | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.71 | |
| Persistency — 49th Month | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.68 | |
| Persistency — 61st Month | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.59 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||
| Investor Complaints — Received | 0.00 | 4.00 | 5.00 | 0.00 | 3.00 | 7.00 | |
| Investor Complaints — Disposed | 0.00 | 4.00 | 5.00 | 0.00 | 3.00 | 7.00 | |
| Related-party Transactions — During the Period | 8,176.8 | — | 5,470.8 | — | 7,058.9 | — | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||
| Other Operating Expenses | 480.5 | 376.2 | 649.0 | 844.8 | 865.7 | 782.5 | |